Today’s AI is underwhelmingly serving the healthcare industry. Deadlocked by immutable regulations, and rightfully so, safeguarding patient privacy stymies AI developers from applying AI model development with real ground truth patient data. AI has the potential to generate almost $150 billion in estimated potential annual benefits by 2026 to the global healthcare system, but that outcome is largely tied to how efficiently AI developers can access significant amounts of medical data.
According to Mckinsey, 28 percent of healthcare executives reported using AI in their product and/or service development, ranking the third lowest among all industries. Of that fraction, only 8 percent stated that data was accessible by their AI systems. Healthcare data is inoperable and that’s stifling the integration of AI into healthcare, which ironically collects the most data among any industry.
In virtue of the hampering data dynamics, Israeli AI, cybersecurity, data science, and healthcare experts Omer Dror, Ofir Farchy and Dr. Robert Eisdorfer set out to eliminate the barriers constricting medical innovations. They founded Lynx.MD to enable data sharing between hospitals and the community of med-tech and life sciences companies, significantly shortening data access times and the time to market of new digital health technologies. Their cloud-based platform lets AI developers access and study hospital data, and facilitates AI’s integration into healthcare without concern of data privacy and security.
